GoodRx (NASDAQ: GDRX)
GoodRx Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
GoodRx Company Info
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2015 and is headquartered in Santa Monica, CA.
News & Analysis
Why GoodRx Holdings Stock Triumphed on Thursday
Why GoodRx Holdings Stock Was Sinking This Week
The company is growing key fundamentals. However, the improvements weren't enough to impress the market.
Investing in Telemedicine and Telehealth Stocks
Why GoodRx Surged Today
The prescription-drug upstart got an upgrade from Wall Street.
Why GoodRx Stock Soared Today
The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.
Why GoodRx Holdings Stock Dived by Nearly 19% Today
An unimpressive quarter featuring weak guidance led investors to hit the sell button.
Why Shares of GoodRx Holdings Climbed This Week
The company agreed to a plan that will use its prescription pricing to help CVS Caremark members.
Why Shares of GoodRx Holdings Fell This Week
The company announced a C-suite shakeup earlier in the week.
Valuation
Podcast Episodes
Earnings Transcripts
GoodRx (GDRX) Q4 2024 Earnings Call Transcript
GDRX earnings call for the period ending December 31, 2024.
GoodRx (GDRX) Q3 2024 Earnings Call Transcript
GDRX earnings call for the period ending September 30, 2024.
GoodRx (GDRX) Q2 2024 Earnings Call Transcript
GDRX earnings call for the period ending June 30, 2024.
GoodRx (GDRX) Q1 2024 Earnings Call Transcript
GDRX earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.